Neuromuscular Disease

Neuromuscular disease encompasses various disease and disorders which affects the nerves that control muscle function and neuromuscular system. Neuromuscular disorders can generate difficulties with the nerves carrying information back to the brain, nerves that control voluntary muscles, and transmission between nerve and muscles. These disorders can make the muscles weak and may lose functioning as well.

Some signs and symptoms of neurological disorders or neurological disease are muscle loss, muscle weakness, double vision, trouble breathing and swallowing, numbness, balancing problem, and movement issues. Signs and symptoms for some of the neurological disorders can be visible in the infant stage as well. In general, there is no cure for these disorders. But prevention, prognosis, and management of these diseases vary according to the severity and types of these disorders.

Sub-tracks: 

• Spinal muscular atrophy
• Myasthenia gravis
• Researches on Neuromuscular disease and disorders
• Myositis, including polymyositis and dermatomyositis
• Myopathy
• Charcot-Marie-Tooth disease
• Amyotrophic lateral sclerosis (ALS)
• Neuromuscular Disorders
• Multiple sclerosis
• Neuromuscular disease causes and risk factors
• Autoimmune disorders
• Peripheral neuropathy
• Muscular dystrophy

Market Analysis: The global neuromuscular disorders therapeutics market is expected to increase by USD 6.05 billion from 2019 to 2023, with a compound annual growth rate (CAGR) of over 14% from 2021 to 2023. A number of innovative therapies for the treatment of diverse indications have been approved in the neuromuscular disorders therapeutics market. This is primarily owing to advanced study on severely morbid and progressive indications.One of the major neuromuscular illnesses for which treatment approvals have been granted is spinal muscular atrophy. During the period 2019-2023, the global neuromuscular disease treatments market would rise by USD 6.05 billion.